nad has been researched along with Cranial Nerve II Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belkin, M; Schwartz, M; Yoles, E | 1 |
| Ben-Bassat, S; Duvdevani, R; Lavie, V; Schwartz, M; Yoles, E; Zalish, M | 1 |
| Mukai, N | 1 |
3 other study(ies) available for nad and Cranial Nerve II Injuries
| Article | Year |
|---|---|
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy.
Topics: Action Potentials; Animals; Axons; Brain Injuries; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Electrophysiology; Energy Metabolism; Evoked Potentials, Visual; Male; NAD; Nerve Crush; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.
Topics: Animals; Axons; Cell Count; Cell Survival; Disease Models, Animal; G(M1) Ganglioside; Injections, Intraperitoneal; Male; NAD; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence | 1992 |
[Morphological studies on the axoplasmic response in retina and optic nerve injuries].
Topics: Animals; Axons; Diathermy; Dogs; Haplorhini; Histocytochemistry; L-Lactate Dehydrogenase; Lasers; Light Coagulation; Methods; Microscopy, Electron; Mitochondria; NAD; NADP; Nerve Regeneration; Neurons; Optic Nerve; Optic Nerve Injuries; Rabbits; Rats; Retina; Staining and Labeling; Swine; Time Factors | 1968 |